The case for verapamil use in alarming jellyfish stings remains (multiple letters)

Toxicon

Volumn 44, Issue 8, 2004, Pages 817-818

  Burnett, Joseph W ^a   Calton, Gary J ^a   Isbister, Geoffrey K ^b   Ramasamy, Sharmaine ^b   Seymour, Jamie E ^c   Hodgson, Wayne C ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MONASH UNIVERSITY   (Australia)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

Verapamil

Indexed keywords

ANTIHYPERTENSIVE AGENT; CARDIOTOXIN; HALOTHANE; JELLYFISH VENOM; SNAKE VENOM; UNCLASSIFIED DRUG; VENOM; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOTOXICITY; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG HALF LIFE; FATALITY; GUINEA PIG; IN VIVO STUDY; INFUSION; ISOLATION PROCEDURE; JELLYFISH; LETTER; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

ANIMALIA; CAVIA PORCELLUS; SCYPHOZOA; SERPENTES; SUS SCROFA;

EID: 8644277013     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2004.08.003     Document Type: Letter

References (0)